70 related articles for article (PubMed ID: 22028623)
1. Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survival.
Sayed HAR; Hetta HF; Shafik EA; Zahran AM
Cancer Immunol Immunother; 2021 Mar; 70(3):755-761. PubMed ID: 32945943
[TBL] [Abstract][Full Text] [Related]
2. Epileptic seizures increase circulating endothelial cells in peripheral blood as early indicators of cerebral vascular damage.
Parfenova H; Leffler CW; Tcheranova D; Basuroy S; Zimmermann A
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1687-98. PubMed ID: 20363895
[TBL] [Abstract][Full Text] [Related]
3. Isolation of Highly Purified and Viable Retinal Endothelial Cells.
Chavkin NW; Walsh K; Hirschi KK
J Vasc Res; 2021; 58(1):49-57. PubMed ID: 33022674
[TBL] [Abstract][Full Text] [Related]
4. CD146, a therapeutic target involved in cell plasticity.
Wu Z; Zang Y; Li C; He Z; Liu J; Du Z; Ma X; Jing L; Duan H; Feng J; Yan X
Sci China Life Sci; 2024 Apr; ():. PubMed ID: 38613742
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
Wang K; Wang X; Pan Q; Zhao B
Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients.
Asante DB; Mohan GRKA; Acheampong E; Ziman M; Calapre L; Meniawy TM; Gray ES; Beasley AB
Sci Rep; 2023 Feb; 13(1):2552. PubMed ID: 36781954
[TBL] [Abstract][Full Text] [Related]
7. Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer.
Ma G; Jiang Y; Liang M; Li J; Wang J; Mao X; Veeramootoo JS; Xia T; Liu X; Wang S
Ther Adv Med Oncol; 2020; 12():1758835920918470. PubMed ID: 32489429
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation.
Danova M; Comolli G; Manzoni M; Torchio M; Mazzini G
Mol Clin Oncol; 2016 Jun; 4(6):909-917. PubMed ID: 27284422
[TBL] [Abstract][Full Text] [Related]
9. Cancer subclonal genetic architecture as a key to personalized medicine.
Rehemtulla A
Neoplasia; 2013 Dec; 15(12):1410-20. PubMed ID: 24403863
[TBL] [Abstract][Full Text] [Related]
10. Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.
Rehemtulla A
Neoplasia; 2012 Dec; 14(12):1278-89. PubMed ID: 23308059
[TBL] [Abstract][Full Text] [Related]
11. Circulating endothelial cells and tumor blood volume as predictors in lung cancer.
Wang J; Xiao J; Wei X; Wang L; Lin L; Liu Z; Wang X; Sun B; Li K
Cancer Sci; 2013 Apr; 104(4):445-52. PubMed ID: 23298271
[TBL] [Abstract][Full Text] [Related]
12. The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.
Triozzi PL; Achberger S; Aldrich W; Singh AD; Grane R; Borden EC
J Transl Med; 2012 Dec; 10():241. PubMed ID: 23217102
[TBL] [Abstract][Full Text] [Related]
13. Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy.
Kondo S; Ueno H; Hashimoto J; Morizane C; Koizumi F; Okusaka T; Tamura K
BMC Cancer; 2012 Jun; 12():268. PubMed ID: 22731825
[TBL] [Abstract][Full Text] [Related]
14. The interconnectedness of cancer cell signaling.
Rehemtulla A
Neoplasia; 2011 Dec; 13(12):1183-93. PubMed ID: 22241964
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.
Starlinger P; Brugger P; Reiter C; Schauer D; Sommerfeldt S; Tamandl D; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C
Neoplasia; 2011 Oct; 13(10):980-90. PubMed ID: 22028623
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype.
Tropea MM; Harper BJ; Graninger GM; Phillips TM; Ferreyra G; Mostowski HS; Danner RL; Suffredini AF; Solomon MA
Thromb Haemost; 2014 Oct; 112(4):770-80. PubMed ID: 25057108
[TBL] [Abstract][Full Text] [Related]
17. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
[TBL] [Abstract][Full Text] [Related]
18. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK
J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
